MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

Tandem Diabetes Care Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

15.55 -3.66

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

15.48

Max

15.98

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-131M

-131M

Pardavimai

-48M

234M

Pelno marža

-55.693

Darbuotojai

2,650

EBITDA

-121M

-116M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+132.65% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

1.1B

Ankstesnė atidarymo kaina

19.21

Ankstesnė uždarymo kaina

15.55

Naujienos nuotaikos

By Acuity

50%

50%

174 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Tandem Diabetes Care Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-11 22:19; UTC

Įsigijimai, susijungimai, perėmimai

FCC Approves U.S. Cellular Sale to T-Mobile

2025-07-11 17:28; UTC

Pagrindinės rinkos jėgos

SharpLink Gaming Gains on Ethereum Purchase

2025-07-11 16:57; UTC

Uždarbis

BASF Cuts Outlook on Global Economy Uncertainty

2025-07-12 17:01; UTC

Uždarbis

That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com

2025-07-12 14:53; UTC

Uždarbis

That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com

2025-07-12 02:24; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

2025-07-11 21:45; UTC

Rinkos pokalbiai

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

2025-07-11 19:46; UTC

Įsigijimai, susijungimai, perėmimai

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

2025-07-11 19:45; UTC

Rinkos pokalbiai

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

2025-07-11 19:05; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

2025-07-11 18:18; UTC

Rinkos pokalbiai

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

2025-07-11 17:35; UTC

Rinkos pokalbiai

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

2025-07-11 17:26; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

2025-07-11 16:53; UTC

Rinkos pokalbiai

Crude Futures Add to Early Gains -- Market Talk

2025-07-11 16:42; UTC

Uždarbis

BASF Cuts Outlook on Global Economic Uncertainty

2025-07-11 16:08; UTC

Rinkos pokalbiai

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

2025-07-11 16:05; UTC

Uždarbis

BASF Will Publish Half-Year Results on July 30

2025-07-11 16:04; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-11 16:04; UTC

Rinkos pokalbiai

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

2025-07-11 16:03; UTC

Uždarbis

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

2025-07-11 16:02; UTC

Uždarbis

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

2025-07-11 16:01; UTC

Uždarbis

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

2025-07-11 16:00; UTC

Uždarbis

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

2025-07-11 15:59; UTC

Uždarbis

BASF Cuts 2025 Earnings View

2025-07-11 15:58; UTC

Uždarbis

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

2025-07-11 15:57; UTC

Uždarbis

BASF 2Q EBIT Before Special Items EUR810M

2025-07-11 15:54; UTC

Uždarbis

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

Akcijų palyginimas

Kainos pokytis

Tandem Diabetes Care Inc Prognozė

Kainos tikslas

By TipRanks

132.65% į viršų

12 mėnesių prognozė

Vidutinis 36.27 USD  132.65%

Aukščiausias 75 USD

Žemiausias 14 USD

Remiantis 16 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Tandem Diabetes Care Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

16 ratings

9

Pirkti

5

Laikyti

2

Parduoti

Techninis įvertinimas

By Trading Central

21.29 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

174 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.